GPT and metabolic dysfunction-associated steatotic liver disease: A number of studies involving animals and humans have demonstrated the benefits of pro/synbiotics in NAFLD, such as improving the hepatic steatosis level, reducing hepatic inflammation, and improving biochemical parameters such as alanine aminotransferase (ALT), fasting glucose, and lipid profiles [10,11,12].